Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MLNR | O43193 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12987447 | 1.00 | SHBG (0.50) | SHBGEPHX1TP53CYP2D6LMNA | |
| SCHEMBL3036277 | 0.98 | SHBG (0.46) | SHBGEPHX1 | |
| SCHEMBL9416078 | 0.93 | — | — | |
| SCHEMBL9415959 | 0.88 | — | — | |
| SCHEMBL1335896 | 0.83 | SHBG (0.41) | SHBGEPHX1TP53ALDH1A1CYP1A2 | |
| SCHEMBL6988843 | 0.79 | SHBG (0.39) | SHBGEPHX1CYP1A2TSHRSIGMAR1 | |
| SCHEMBL7458138 | 0.78 | SHBG (0.38) | SHBGEPHX1CYP1A2TSHR | |
| SCHEMBL6590036 | 0.77 | SHBG (0.50) | SHBGEPHX1TP53LMNAKDM4E | |
| SCHEMBL27526699 | 0.77 | SHBG (0.50) | SHBGEPHX1TP53LMNAKDM4E | |
| SCHEMBL19812674 | 0.77 | EPHX1 (0.50) | SHBGEPHX1TP53CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1301829-A4 | RADIATION SENSITIVE COMPOSITIONS CONTAINING IMAGE QUALITY AND PROFILE ENHANCEMENT ADDITIVES | FUJIFILM ELECTRONIC MATERIALS (US) | 2006-06-28 | — | — | EP | claimed |
| EP-1301829-A1 | RADIATION SENSITIVE COMPOSITIONS CONTAINING IMAGE QUALITY AND PROFILE ENHANCEMENT ADDITIVES | ARCH SPECIALTY CHEMICALS, INC. (US) | 2003-04-16 | — | — | EP | claimed |
| US-6514664-B1 | Radiation sensitive compositions containing image quality and profile enhancement additives | ARCH SPECIALTY CHEMICALS, INC. | 2003-02-04 | — | — | US | claimed |
| WO-2002008834-A1 | RADIATION SENSITIVE COMPOSITIONS CONTAINING IMAGE QUALITY AND PROFILE ENHANCEMENT ADDITIVES | ARCH SPECIALTY CHEMICALS, INC. (US) | 2002-01-31 | — | — | WO | claimed |
| WO-2023085402-A1 | PEPTIDE HAVING INHIBITORY ACTIVITY ON FORMATION OF LEUKOCYTE EXTRACELLULAR TRAPS | 平橋 淳一 | 2023-05-19 | — | — | WO | disclosed |
| US-11566047-B2 | Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof | TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES (JP) | 2023-01-31 | — | — | US | disclosed |
| US-20190177370-A1 | PEPTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR PRODRUG THEREOF | TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES (JP) | 2019-06-13 | — | — | US | disclosed |
| US-20170073373-A1 | POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICS | SPERO THERAPEUTICS, INC. | 2017-03-16 | — | — | US | disclosed |
| US-8383617-B2 | Treatment of protein aggregation diseases | PAD PHARMA LIMITED (GB) | 2013-02-26 | — | — | US | disclosed |
| US-8138342-B2 | 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds | High Point Pharmacueticals, LLC (US) | 2012-03-20 | — | — | US | disclosed |
| US-7892737-B2 | Compositions, kits and methods pertaining to stability modulation of PNA oligomer/nucleic acid complexes | Life Technologies Corporation (US) | 2011-02-22 | — | — | US | disclosed |
| US-7858349-B2 | Anti-cancer compounds | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2010-12-28 | — | — | US | disclosed |
| US-6281221-B1 | Substituted 1,3-dioxan-5-ylamino-hererocyclic compounds, processes for their preparation and their use as pest control compositions | HOECHST SCERING AGREVO GMBH (DE) | 2001-08-28 | — | — | US | disclosed |
| US-6265350-B1 | CONTROLLING HARMFUL FUNGI, INSECTS, ACARINA, MOLLUSKS AND NEMATODES | HOECHST SCHERING AGREVO GMBH (DE) | 2001-07-24 | — | — | US | disclosed |
| US-6107299-A | INSECTICIDES; MITICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 2000-08-22 | — | — | US | disclosed |
| WO-1999059979-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES | AVENTIS CROPSCIENCE GMBH (DE) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999059978-A1 | SUBSTITUTED NITROGEN HETEROCYCLES AND THEIR USE AS PESTICIDES | AVENTIS CROPSCIENCE GMBH (DE) | 1999-11-25 | — | — | WO | disclosed |
| US-5889012-A | INSECTICIDE, ACARICIDES, FUNGICIDES | HOECHST-SCHERING AGREVO GMBH (DE) | 1999-03-30 | — | — | US | disclosed |
| US-5859009-A | Substituted spiroalkylamino and alkoxy heterocycles, processes for their preparation, and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1999-01-12 | — | — | US | disclosed |
| EP-0599265-A1 | Antibacterial, antifungal compound and its production method | Takeda Chemical Industries, Ltd. (JP) | 1994-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177370-A1 | PEPTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR PRODRUG THEREOF | MYOF, MSTN, VIP | SHBG 661/4885EPHX1 4726/4885TP53 1820/4885 |
| US-20170073373-A1 | POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICS | PNISR, MRPS18A, RRP15 | SHBG 4229/4885EPHX1 4404/4885TP53 3079/4885 |
| US-11566047-B2 | Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof | MYOF, MSTN, VIP | SHBG 661/4885EPHX1 4726/4885TP53 1820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.